These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31144751)

  • 41. Hydrodistension with or without fulguration of hunner lesions for interstitial cystitis: Long-term outcomes and prognostic predictors.
    Niimi A; Nomiya A; Yamada Y; Suzuki M; Fujimura T; Fukuhara H; Kume H; Igawa Y; Homma Y
    Neurourol Urodyn; 2016 Nov; 35(8):965-969. PubMed ID: 26208131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Editorial comment on: treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions?
    Cardoso LE
    Eur Urol; 2008 Jul; 54(1):76-7. PubMed ID: 18403094
    [No Abstract]   [Full Text] [Related]  

  • 43. Editorial comment on: treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence-based decisions?
    Novara G; Ficarra V
    Eur Urol; 2008 Jul; 54(1):76. PubMed ID: 18403095
    [No Abstract]   [Full Text] [Related]  

  • 44. Editorial comment on: treatment of bladder pain syndrome/interstitial cystitis 2008: can we make evidence based decisions?
    Lazzeri M
    Eur Urol; 2008 Jul; 54(1):77-8. PubMed ID: 18403098
    [No Abstract]   [Full Text] [Related]  

  • 45. Sensory Hyperinnervation Distinguishes Bladder Pain Syndrome/Interstitial Cystitis from Overactive Bladder Syndrome.
    Regauer S; Gamper M; Fehr MK; Viereck V
    J Urol; 2017 Jan; 197(1):159-166. PubMed ID: 27378135
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Editorial comment from Dr. Hanno to hypersensitive bladder: a solution to confused terminology and ignorance concerning interstitial cystitis.
    Hanno P
    Int J Urol; 2014 Apr; 21 Suppl 1():48. PubMed ID: 24807496
    [No Abstract]   [Full Text] [Related]  

  • 47. Correlation of cystoscopically confirmed periureterally located hunner lesion with vesicoureteral reflux: preliminary study in patients with interstitial cystitis.
    Lee JE; Yi BH; Lee HK; Lee MH; Kim YH
    AJR Am J Roentgenol; 2015 Apr; 204(4):W457-60. PubMed ID: 25794095
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Patterns and predictors of Hunner lesion recurrence in patients with interstitial cystitis.
    Han JY; Shin JH; Choo MS
    Neurourol Urodyn; 2019 Jun; 38(5):1392-1398. PubMed ID: 30945347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pathology and terminology of interstitial cystitis/bladder pain syndrome: A review.
    Akiyama Y; Homma Y; Maeda D
    Histol Histopathol; 2019 Jan; 34(1):25-32. PubMed ID: 30015351
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Editorial Comment to Clinical guidelines for interstitial cystitis/bladder pain syndrome.
    Sawada N
    Int J Urol; 2020 Jul; 27(7):589-590. PubMed ID: 32542820
    [No Abstract]   [Full Text] [Related]  

  • 51. Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.
    Vera PL; Preston DM; Moldwin RM; Erickson DR; Mowlazadeh B; Ma F; Kouzoukas DE; Meyer-Siegler KL; Fall M
    Urology; 2018 Jun; 116():55-62. PubMed ID: 29580781
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclosporine A for refractory interstitial cystitis/bladder pain syndrome: experience of 3 tertiary centers.
    Forrest JB; Payne CK; Erickson DR
    J Urol; 2012 Oct; 188(4):1186-91. PubMed ID: 22901569
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Downregulation of WNT11 is associated with bladder tissue fibrosis in patients with interstitial cystitis/bladder pain syndrome without Hunner lesion.
    Choi D; Han JY; Shin JH; Ryu CM; Yu HY; Kim A; Lee S; Lim J; Shin DM; Choo MS
    Sci Rep; 2018 Jun; 8(1):9782. PubMed ID: 29955137
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Editorial comment from professor Dinis to Potential therapeutic effect of intravesical botulinum toxin type A on bladder pain syndrome/interstitial cystitis.
    Oliveira PD
    Int J Urol; 2014 Apr; 21 Suppl 1():56. PubMed ID: 24807498
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical and psychological parameters associated with pain pattern phenotypes in women with interstitial cystitis/bladder pain syndrome.
    Nickel JC; Tripp DA;
    J Urol; 2015 Jan; 193(1):138-44. PubMed ID: 25092637
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hunner-Type (Classic) Interstitial Cystitis: A Distinct Inflammatory Disorder Characterized by Pancystitis, with Frequent Expansion of Clonal B-Cells and Epithelial Denudation.
    Maeda D; Akiyama Y; Morikawa T; Kunita A; Ota Y; Katoh H; Niimi A; Nomiya A; Ishikawa S; Goto A; Igawa Y; Fukayama M; Homma Y
    PLoS One; 2015; 10(11):e0143316. PubMed ID: 26587589
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Editorial Comment from Dr Hanno to Pathophysiology of interstitial cystitis.
    Hanno P
    Int J Urol; 2019 Jun; 26 Suppl 1():16. PubMed ID: 31144760
    [No Abstract]   [Full Text] [Related]  

  • 58. Therapeutic effects of endoscopic ablation in patients with Hunner type interstitial cystitis.
    Ko KJ; Chung H; Suh YS; Lee SW; Kim TH; Lee KS
    BJU Int; 2018 Apr; 121(4):659-666. PubMed ID: 29232035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Editorial comment on: insight into urogynecologic features of women with interstitial cystitis/painful bladder syndrome.
    Kadioglu A; Sanli O
    Eur Urol; 2008 Nov; 54(5):1152. PubMed ID: 18276065
    [No Abstract]   [Full Text] [Related]  

  • 60. Tanezumab Reduces Pain in Women with Interstitial Cystitis/Bladder Pain Syndrome and Patients with Nonurological Associated Somatic Syndromes.
    Nickel JC; Mills IW; Crook TJ; Jorga A; Smith MD; Atkinson G; Krieger JN
    J Urol; 2016 Apr; 195(4 Pt 1):942-8. PubMed ID: 26576710
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.